Successful Rapid Oral Desensitization to Ibrutinib in a Patient With Severe Immediate Hypersensitivity Reaction

Clin Lymphoma Myeloma Leuk. 2021 Oct;21(10):e745-e747. doi: 10.1016/j.clml.2021.05.014. Epub 2021 May 24.

¹ Division and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne. Electronic address: gerasimos.tsilimidos@chuv.ch.
² Division of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
³ Division and Central Laboratory of Hematology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne.

No abstract available

Keywords: Desensitization; Hypersensitivity; Ibrutinib; Primary central nervous system lymphoma.

Publication types